Agilent Technologies, Inc. - Diagnostics and Genomics ClearSeq Comprehensive Cancer,16, XT
The Agilent ClearSeq Comprehensive Cancer, 16 reactions, XT (part number 5190-8011) is a next-generation sequencing (NGS) target enrichment panel designed for comprehensive cancer research. This panel enables the detection of genetic variants across a broad range of cancer-related genes, supporting the identification of mutations relevant to cancer diagnostics and research. The kit is optimized for use with Agilent's SureSelect XT workflow, providing high sensitivity and specificity for variant detection. It is suitable for use with DNA samples and is compatible with major NGS platforms, facilitating streamlined library preparation and efficient sequencing of cancer-associated genomic regions.